Home/Filings/4/0001209191-21-020591
4//SEC Filing

Patton Stephana Eilene 4

Accession 0001209191-21-020591

CIK 0001305253other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 7:36 PM ET

Size

7.4 KB

Accession

0001209191-21-020591

Insider Transaction Report

Form 4
Period: 2021-03-12
Transactions
  • Award

    Common Stock

    2021-03-12+11,87517,948 total
  • Award

    Stock Option (Right to Buy)

    2021-03-12+71,25071,250 total
    Exercise: $9.99Exp: 2031-03-11Common Stock (71,250 underlying)
Footnotes (3)
  • [F1]Represents shares underlying Restricted Stock Units award that will vest in three equal annual installments measured from March 12, 2021.
  • [F2]Includes 1,253 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on March 5, 2021.
  • [F3]The option vests in equal monthly installments over 48 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date.

Issuer

Eiger BioPharmaceuticals, Inc.

CIK 0001305253

Entity typeother

Related Parties

1
  • filerCIK 0001698237

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:36 PM ET
Size
7.4 KB